To carry out the study, retrospective clinical data was collected by researchers from clinicians and caretakers of 10 children with drug-resistant epilepsy. The researchers ensured that the 10 patients recruited for the research had not responded to any CBD products. The children recruited were of the average age of six but ranged between 1 to 13 years. These kids had a range of epilepsies and various kinds of co-existing issues like learning abilities, global developmental delay, and infantile spasms.
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…
Come along on an Emerald Triangle road trip with Lindsay MaHarry to see some of…
This month an Iowa church got what every sacramental-plant congregation dreams about: a path to…
The cannabis industry does not need another study, another tax revenue report, or another state-level…